Skip to main content
Clinical Trials/IRCT20150529022468N5
IRCT20150529022468N5
Completed
Phase 2

Comparison of efficacy and safety of intra lesional tranexamic acid injection versus topical Kligman’s formula application in the treatment of macular amyloidosis

Iran University of Medical Sciences0 sites40 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Iran University of Medical Sciences
Enrollment
40
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age range 18 to 50 years
  • Suffering from macular amyloidosis

Exclusion Criteria

  • Pregnant or lactating women
  • History of cardiovascular disease
  • Keloid patients
  • Patients taking anticoagulants
  • Any allergy to the study drugs
  • History of bleeding disorder
  • Topical treatment three months before entering the study
  • No consent to participate in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials